In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies.
The MSc in Experimental and Translational Therapeutics (ETT) is moving to NDORMS. Jointly run with the Department of Continuing Education, the move will expand the already broad range of disciplines covered in the course.
To mark World Arthritis Day, the British Society for Rheumatology has announced the launch of a new toolkit that will help patients take more control of their arthritis treatment.
NDORMS researchers have received funding from the Medical Research Council (MRC) to explore a new treatment for anterior cruciate ligament (ACL) injuries which could provide relief for thousands of young people suffering from knee pain.
Dr Kate Coldwell has joined the Oxford Centre for Microbiome Studies at the Kennedy Institute to study the links between liver disease and gut bacteria, having been awarded the Daphne Jackson Fellowship, co-funded by the Kennedy Trust for Rheumatology Research (KTRR) and the Medical Research Council.
Professor Sir Ravinder Maini and Professor Sir Marc Feldmann have jointly received The Royal Society\u2019s Royal Medal (Applied) for inventing anti-TNF therapy to treat rheumatoid arthritis (RA), bringing it from bench to bedside in one of the biggest success stories of modern medicine.
Tal Arnon, Stephanie Dakin and Catherine Swales have each been awarded title of \u2018Full Professor\u2019 in the University of Oxford's 2024 Recognition of Distinction exercise.
\u00a328.5m in funding has been announced to support functional genomics research across the UK, including a research cluster at NDORMS that will deliver insights into musculoskeletal health and disease.
A new model to predict the risk of serious complications after shoulder replacement surgery has been developed in a collaboration between researchers from the University of Oxford, University of Bristol, and University of Copenhagen. The model could be an important tool to help both patients and doctors make more informed decisions about this common procedure.
The scTrends consortium has published its first report that sheds light on the current state of the commercial single-cell and spatial genomics industry and its potential impact on drug discovery and patient care.
We welcome Nicole Stoffel who has joined the Botnar Institute as a new Principal Investigator. Nicole will be establishing her group to better understand human iron metabolism, kinetics and physiology with a specific focus on the role iron plays in the immune response and the impact of iron deficiency on vaccine effectiveness.
Research has unveiled the intricate cellular landscape of healthy human hamstring tendons, shedding new light on this vital yet often overlooked component of our musculoskeletal system.
Early results of an international study examining the risk of arthritis for people with psoriasis have shown a high burden of joint symptoms in 712 patients \u2013 25% of the total studied so far.
SITU-NDORMS has announced the launch of three major new clinical trials. Funded by the NIHR, these studies are providing evidence for the treatment of chronic low back pain, knee osteoarthritis, and ACL injuries.
Daniel Prieto-Alhambra from NDORMS is to lead a new co-ordination centre for a pilot real-world evidence network to utilise data gathered from multiple UK sources.
![\"Man](\"https://www.ndorms.ox.ac.uk/news/cellular-roadmap-reveals-new-paths-to-treating-inflammatory-bowel-disease/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n